In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose. | Ann Intern Med;174(3): JC28, 2021 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.

Chagla, Zain.

Chagla Z; McMaster University, Hamilton, Ontario, Canada (Z.C.).

Ann Intern Med ; 174(3): JC28, 2021 03.

Article in English | MEDLINE | ID: covidwho-1512996

ABSTRACT

ABSTRACT

SOURCE CITATION Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384403-16. 33378609.

Subject(s)

COVID-19; Vaccines; Adult; COVID-19 Vaccines; Humans; RNA, Messenger; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Adult / Humans Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Adult / Humans Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article